Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
09/24/2003 | EP1345955A2 Lactam dipeptide and its use in inhibiting beta-amyloid peptide release |
09/24/2003 | EP1345950A2 Inositol derivatives for increasing chloride secretion and inhibiting inflammation |
09/24/2003 | EP1345946A1 Macroheterocylic compounds useful as kinase inhibitors |
09/24/2003 | EP1345942A2 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists |
09/24/2003 | EP1345941A1 Cyclin-dependent kinase (cdk) and glycolene synthase kinase-3 (gsk-3) inhibitors |
09/24/2003 | EP1345937A1 Quinuclidine carbamate derivatives and their use as m3 antagonists |
09/24/2003 | EP1345936A1 Method for producing the anticholinergic agent tiotropium bromide |
09/24/2003 | EP1345935A2 Piperidine derivatives as subtype selective n-methyl-d-aspartate antagonists |
09/24/2003 | EP1345932A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
09/24/2003 | EP1345931A2 Cysteine protease inhibitors |
09/24/2003 | EP1345929A2 Pyrazole compounds useful as protein kinase inhibitors |
09/24/2003 | EP1345928A2 Pyrazole compounds useful as protein kinase inhibitors |
09/24/2003 | EP1345927A1 Pyrazole compounds useful as protein kinase inhibitors |
09/24/2003 | EP1345926A2 Pyrazole compounds useful as protein kinase inhibitors |
09/24/2003 | EP1345925A2 Pyrazole compounds useful as protein kinase inhibitors |
09/24/2003 | EP1345922A1 Pyrazole compounds useful as protein kinase inhibitors |
09/24/2003 | EP1345920A1 Novel sulfamides and their use as endothelin receptor antagonists |
09/24/2003 | EP1345919A2 Novel c-glycoside derivatives and use thereof |
09/24/2003 | EP1345918A1 Chemical compounds |
09/24/2003 | EP1345916A1 Substituted oxazoles and thiazoles as hppar alpha agonists |
09/24/2003 | EP1345910A1 Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof |
09/24/2003 | EP1345909A1 Phenylacetamido-pyrazole derivatives and their use as antitumor agents |
09/24/2003 | EP1345907A2 7-heterocyclyl quinoline and thieno 2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
09/24/2003 | EP1345902A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
09/24/2003 | EP1345900A1 Guanidine and amidine derivatives as factor xa inhibitors |
09/24/2003 | EP1345898A2 Teracyclic carbazole derivates and their use as spla2 inhibitors |
09/24/2003 | EP1345896A1 Crystalline forms of atorvastatin |
09/24/2003 | EP1345895A1 Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism |
09/24/2003 | EP1345892A2 Acylaminoalkyl-substituted benzenesulfonamide derivatives |
09/24/2003 | EP1345891A1 Glucagon antagonist/inverse agonist |
09/24/2003 | EP1345890A1 Glucagon antagonists/inverse agonists |
09/24/2003 | EP1345629A2 Particles for inhalation having sustained release properties |
09/24/2003 | EP1345626A2 Novel pharmaceutical compositions based on anticholinergic agents and dopamine agonists |
09/24/2003 | EP1345619A2 Use of a composition for the stimulation of nerve growth, the inhibition of scar tissue formation, the reduction of secondary damage and/or the accumulation of macrophages |
09/24/2003 | EP1345618A2 Use of intermediate-conductance potassium channels and modulators for the diagnosis and treatment of illnesses having disturbed keratinocyte activity |
09/24/2003 | EP1345616A2 Reducing cellular damage in the human body |
09/24/2003 | EP1345610A1 Method of treatment |
09/24/2003 | EP1345609A1 Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists |
09/24/2003 | EP1345607A1 Therapeutic combination of amlodipine and benazepril / benazeprilat |
09/24/2003 | EP1345605A1 Thermoformable solid pharmaceutical composition for controlled release of perindopril |
09/24/2003 | EP1345600A1 New clinical treatment |
09/24/2003 | EP1345598A2 The use of ppar-gamma agonists for treating diseases characterised by neuron degeneration, neuron injury or impaired plasticity |
09/24/2003 | EP1345568A2 Stable skin conditioning compositions containing retinoid boosters |
09/24/2003 | EP1345567A2 Calcium channel transport polynucleotides, polypeptides, and antibodies |
09/24/2003 | EP1345501A1 Nutritional and therapeutical preparations having antioxidant activity |
09/24/2003 | EP1272489B1 Process for preparing crystalline form i of cabergoline |
09/24/2003 | EP1259512B1 Pteridine compounds for the treatment of psoriasis |
09/24/2003 | EP1252163B1 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
09/24/2003 | EP1200093B1 Use of 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine in the treatment of gi disorders |
09/24/2003 | EP1178965B1 Quinoline derivatives as inhibitors of mek enzymes |
09/24/2003 | EP1165558B1 Derivatives of pyrimido[6,1-a]isoquinolin-4-one |
09/24/2003 | EP1124554B1 Pharmaceutical compositions containing tetrahydroisoquinoline compounds |
09/24/2003 | EP1123109B1 Contulakin-g, analogs thereof and uses therefor |
09/24/2003 | EP1117428B1 Compositions and their use for inhibiting angiogenesis |
09/24/2003 | EP1100480B1 Muscarinic antagonists in the treatment of presbyopia |
09/24/2003 | EP1098656B1 Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof |
09/24/2003 | EP1094829B1 Methods for accelerating bone and cartilage growth and repair |
09/24/2003 | EP1054868B1 Substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia |
09/24/2003 | EP1051415B1 Benzamide derivatives as vasopressin antagonists |
09/24/2003 | EP1036061B1 New compounds |
09/24/2003 | EP1021444B1 3-CARBOXAMIDE DERIVATIVES OF 5H-PYRROLO[2,1-c][1,4]-BENZODIAZEPINES |
09/24/2003 | EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
09/24/2003 | EP0973746B1 Substituted 3-cyano quinolines |
09/24/2003 | EP0944618B1 Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use |
09/24/2003 | EP0923543B1 Potassium channel inhibitors |
09/24/2003 | EP0920430B1 Purine derivatives and their use as anti-coagulants |
09/24/2003 | EP0914122B1 Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone |
09/24/2003 | EP0847278B1 Analogs of parathyroid hormone |
09/24/2003 | EP0736022B1 5-(2-imidazolinylamino)benzimidazole derivatives, their preparation and their use as alpha-2 adrenoceptor agonists |
09/24/2003 | CN1444661A Method for detecting growth hormone variations in humans, the variations and their uses |
09/24/2003 | CN1444659A Koji molds and use thereof for preparing cholesterol-lowering products |
09/24/2003 | CN1444654A Novel therapeutic molecular variants and uses thereof |
09/24/2003 | CN1444647A Novel probiotics for pet. food applications |
09/24/2003 | CN1444602A Human receptor proteins, related reagents and methods |
09/24/2003 | CN1444600A Use of ADNF polypeptides for enhancing learning and memory |
09/24/2003 | CN1444596A 16 alpha-methyl or ethyl substituted estrogens |
09/24/2003 | CN1444589A 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
09/24/2003 | CN1444587A Dihydropyridine soft drug and related to composition and method |
09/24/2003 | CN1444585A Crystalline therapeutic agent |
09/24/2003 | CN1444584A N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
09/24/2003 | CN1444581A 3-indolyl-4-phenyl-1H-pyrrole-2, 5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
09/24/2003 | CN1444567A 咪唑衍生物 Imidazole derivatives |
09/24/2003 | CN1444566A Imidazolyl derivatives |
09/24/2003 | CN1444563A Quinoline and quinazoline derivatives |
09/24/2003 | CN1444561A Acetamide derivatives and use thereof as inhibitors of coagulation factors XA and VIIA |
09/24/2003 | CN1444558A Novel N-(2-phenyl-3-aminopropyl) naphtamides |
09/24/2003 | CN1444486A Use of interferon receptor 2c polypeptide chain to enhance anti-growth effects of type I interferons |
09/24/2003 | CN1444484A Immunotherapy treating bacterial or viral infection at mucosal surface with probiotics, and composition therefor |
09/24/2003 | CN1444481A Protease inhibitors |
09/24/2003 | CN1444479A Medicaments containing cilansetron for treating non-obstipated male IBS patients |
09/24/2003 | CN1444478A Use of celecoxib composition for fast pain relief |
09/24/2003 | CN1444477A Thrombopoietin mimetics |
09/24/2003 | CN1444476A Method for reducing exacerbations associated with COPD |
09/24/2003 | CN1443763A Internediate for preparing quinoxaline diketone |
09/24/2003 | CN1443538A Medicine preparation for inhibiting immune deficiency syndrome virus infection and proliferation and its application |
09/24/2003 | CN1122038C Heterocycle fused thiazole derivatives |
09/24/2003 | CN1122037C Thiophene [2,3,-d] hybar X compound and its preparing method, use and medical composition containing it |
09/24/2003 | CN1122022C Substituted oximes as neurokinin antagonists |
09/24/2003 | CN1121859C Process for preparing pharmaceutical composition for treatment or prevention hypertension |
09/24/2003 | CN1121857C Use of gamma RAR specific agonist ligand to increase apoptosis rate |